BioSpace News Archive

uLab Systems, developer of the software platform that enables chairside aligner treatment planning, has completed a $6M Series C financing round which was led by Light Bridge Ventures.

Each year, more Americans are diagnosed with excess weight or obesity as well as many of the more than 50 diseases related to obesity such as type 2 diabetes, hypertension, sleep apnea and heart disease

As the consumer trend of demanding premium-quality apparel for multi-use is on the rise, more brands are partnering with Noble Biomaterials, a global leader in odor elimination and smart fabric solutions, to develop products with Noble’s platform of inherent fiber technologies – allowing them to stay current in the ever-evolving apparel industry.

VALBIOTIS (Paris:ALVAL) (FR0013254851 – ALVAL / PEA/SME eligible), a French Research & Development company committed to scientific innovation for preventing and combating metabolic diseases, today announced the expansion of its Board of Directors with the appointment of Murielle CAZAUBIEL, Director of Development and Medical Affairs at VALBIOTIS.

Today, Cook Medical announced its recent approval from the U.S. FDA for its Zenith Dissection Endovascular System

Shipman & Goodwin LLP today announced that Connecticut’s immediate past Attorney General George Jepsen and the state’s immediate past Chief Deputy Attorney General Perry Zinn Rowthorn have joined the firm as partners in its Hartford office.

Asbury Automotive Group, Inc. (NYSE: ABG) (“Asbury” or the “Company”), one of the largest automotive retail and service companies in the U.S., announced today the rollout of its new healthcare and stock ownership programs.

“Far From Finished” features real-life stories on the battle of addiction and provides a rare look at daily life in recovery

Primary Care Specialties Account for 56% of Matches, with Orthopedic Surgery Leading Specialty Placements

Company’s expanded portfolio now includes rigid and soft touch plastics